Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Repeated dose toxicity: oral

Currently viewing:

Administrative data

Endpoint:
chronic toxicity: oral
Type of information:
migrated information: read-across from supporting substance (structural analogue or surrogate)
Adequacy of study:
supporting study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: Non guideline and non GLP study. Basic data given. Limitations in design and reporting. No NOAEL was identified.

Data source

Reference
Reference Type:
publication
Title:
Zirconium, Niobium, Antimony, Vanadium and Lead in Rats : Life term studies
Author:
Schroeder, H.A. et al.
Year:
1969
Bibliographic source:
J. Nutrition, 100: 59-68

Materials and methods

Test guideline
Qualifier:
no guideline followed
GLP compliance:
no
Limit test:
yes

Test material

Constituent 1
Reference substance name:
Zirconium sulphate
EC Number:
238-694-4
EC Name:
Zirconium sulphate
Cas Number:
14644-61-2
IUPAC Name:
14644-61-2

Test animals

Species:
rat
Strain:
Long-Evans
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source:
- Age at study initiation: Weanlings
- Housing: 4 per cage
- Diet: ad libitum
- Water: ad libitum, basal water

Administration / exposure

Route of administration:
other: oral: feed and drinking water
Vehicle:
unchanged (no vehicle)
Details on oral exposure:
DIET
- Mixing appropriate amounts with: composed of seed rye flour (60% ), dry skim milk (30 % ), corn oil (9% ) and iodized sodium chloride (1% ) with added vitamins and ferrous sulfate)
Analytical verification of doses or concentrations:
not specified
Duration of treatment / exposure:
lifetime
Frequency of treatment:
daily
Doses / concentrationsopen allclose all
Remarks:
Doses / Concentrations:
5 ppm
Basis:
nominal in water
Remarks:
Doses / Concentrations:
2.66 µg/g
Basis:
nominal in diet
No. of animals per sex per dose:
50 or more
Control animals:
yes, concurrent no treatment
Positive control:
No

Examinations

Observations and examinations performed and frequency:
DETAILED CLINICAL OBSERVATIONS: Yes
- Time schedule: daily

BODY WEIGHT: Yes
- Time schedule for examinations: weekly (weaning time to six weeks of age); then monthly

HAEMATOLOGY: Yes
- Time schedule for collection of blood: monthly
- Anaesthetic used for blood collection: Yes
- Animals fasted: Yes, partly (18 hours before collection)

CLINICAL CHEMISTRY: Yes
- Time schedule for collection of blood: monthly
- Animals fasted: Yes, partly (18 hours before collection)
- Parameters examined: serum glucose, cholestrol

URINALYSIS: Yes
- Time schedule for collection of urine: not data
- Metabolism cages used for collection of urine: No data
- Animals fasted: No data
- Parameters examined: glucose, whole protein
Sacrifice and pathology:
GROSS PATHOLOGY: Yes
HISTOPATHOLOGY: Yes

Results and discussion

Results of examinations

Clinical signs:
no effects observed
Mortality:
no mortality observed
Body weight and weight changes:
no effects observed
Food consumption and compound intake (if feeding study):
not examined
Food efficiency:
not examined
Water consumption and compound intake (if drinking water study):
not examined
Ophthalmological findings:
not examined
Haematological findings:
no effects observed
Clinical biochemistry findings:
no effects observed
Urinalysis findings:
effects observed, treatment-related
Behaviour (functional findings):
not examined
Organ weight findings including organ / body weight ratios:
not examined
Gross pathological findings:
no effects observed
Histopathological findings: non-neoplastic:
not examined
Histopathological findings: neoplastic:
no effects observed
Details on results:
Zirconium had no effects on the growth or mature weights of the animals. Survival and longevity were similar to the control group. Female rats fed with zirconium showed higher serum glucose levels at 30, 150, 540 days of age. Furthermore glucose in urine was significantly increased in the animals at 18 months of age. 23% of the control animals were also affected. No significant effects were seen regarding the whole protein content in urine.
Serum cholesterol of fasted animals was significantly higher in males treated with zirconium. The test substance was not tumorigenic and accumulation of zirconium in rat tissue was very poor.

Effect levels

Dose descriptor:
NOAEL
Remarks on result:
not determinable
Remarks:
no NOAEL identified

Target system / organ toxicity

Critical effects observed:
not specified

Applicant's summary and conclusion